ARLINGTON, MA - January 06, 2026 - PRESSADVANTAGE - Drug testing in Chandler, AZ has shifted from a simple checkbox in ...

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...

Resurgence Alcohol & Drug Rehab Riverside has published a new educational resource designed to clarify the differences between Anthem and Blue Cross Blue Shield, two major health insurance providers ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Over the past few years, using artificial intelligence (AI) in drug discovery has stopped being a novelty; instead, it has become part of the standard toolkit across many early-stage programs.

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Structure Therapeutics ...

CHICAGO — A big breakthrough in cancer research and it’s all due to a tiny structure. The science was developed in Chicago. They took an old drug and made it better. The restructured drug appears to ...